Anthony Serrato
Nurse Practitioner · Vista, CANPI 1376138388
Payments from drug & device makers
Across 128 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$385
- Merck$318
- Lilly USA, LLC$247
- GSK$244
- Boehringer Ingelheim$206
- Novo Nordisk$195
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,75897%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 12 | $385 |
| Merck | 12 | $318 |
| Lilly USA, LLC | 13 | $247 |
| GSK | 8 | $244 |
| Boehringer Ingelheim | 10 | $206 |
| Novo Nordisk | 10 | $195 |
| Pfizer | 13 | $176 |
| Kestra Medical Technology Services, Inc. | 3 | $154 |
| Cvrx, Inc. | 9 | $150 |
| Novartis | 7 | $133 |
| Amgen | 6 | $126 |
| Philips North America LLC | 2 | $64 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Lexicon Pharmaceuticals, Inc. | 2 | $53 |
| Tactile Systems Technology Inc | 3 | $49 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $48 |
| AstraZeneca | 2 | $39 |
| Medtronic | 1 | $28 |
| Edwards Lifesciences | 1 | $26 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Abbott | 1 | $21 |
| Bristol Myers Squibb | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,858 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 343 | $415,690 |
| VyndamaxTafamidis | 12 | $310,951 |
| EntrestoSacubitril/Valsartan | 130 | $191,774 |
| XareltoRivaroxaban | 123 | $129,760 |
| OzempicSemaglutide | 83 | $111,829 |
| JardianceEmpagliflozin | 65 | $92,553 |
| Repatha SureclickEvolocumab | 61 | $56,995 |
| MounjaroTirzepatide | 29 | $33,408 |
| Prednisolone Acetate | 367 | $26,172 |
| MultaqDronedarone Hcl | 22 | $21,983 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $14,497 |
| FarxigaDapagliflozin Propanediol | 14 | $13,607 |
| VascepaIcosapent Ethyl | 13 | $6,418 |
| JanuviaSitagliptin Phosphate | 12 | $5,869 |
| Metoprolol Succinate | 298 | $4,360 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Vyndamax | $176 | $726,642355 claims |
| NovartisEntresto | $133 | $191,774130 claims |
| Novo NordiskOzempic | $195 | $111,82983 claims |
| Boehringer IngelheimJardiance | $206 | $92,55365 claims |
| Lilly USA, LLCMounjaro | $247 | $33,40829 claims |
| GSKTrelegy Ellipta | $244 | $14,49712 claims |
| AstraZenecaFarxiga | $39 | $13,60714 claims |
| MerckJanuvia | $318 | $5,86912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Vista
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.